http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014083171-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_270854205211430cfd1dfa8d517a41f8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-15 |
filingDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6606a52e2b16ae574bb0f52475165138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80d5a4d7228ad3bd69878ee88218c442 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b060b24dd8e8159863eeeec2a215dc59 |
publicationDate | 2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2014083171-A1 |
titleOfInvention | Natural compounds for use in the treatment of beta-2 adrenergic receptor related diseases |
abstract | The present invention relates to a knot-wood extract comprising at least one lignan selected from the list comprising (-)-hydroxymatairesinol (two epimers; 7S, 8R, 8'R and 7R, 8R, 8'R), (-)(7S, 8R, 8'R)-hydroxymatairesinol, (+)-lariciresinol, (-)-secoisolariciresinol, liovil and any epimers thereof. The present invention also relates to a method of activating a β2 adrenergic receptor, comprising administering an effective amount of a knot-wood extract of the invention or of at least one lignan selected from the list comprising (-)-hydroxymatairesinol (two epimers; 7S, 8R, 8'R and 7R, 8R, 8'R), (-)(7S, 8R, 8'R)-hydroxymatairesinol, (+)-lariciresinol, (-)-secoisolariciresinol, liovil and any epimers thereof. The present invention also relates to a method of treating a β2 adrenergic receptor related disease in a subject in need thereof, comprising administering to the subject an effective amount of a knot- wood extract of the invention or of at least one lignan selected from the list comprising (-)-hydroxymatairesinol (two epimers; 7S, 8R, 8'R and 7R, 8R, 8'R), (-)(7S, 8R, 8'R)-hydroxymatairesinol, (+)-lariciresinol, (-)-secoisolariciresinol, liovil and any epimers thereof. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018206621-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108712907-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017153555-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021023914-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590101-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201700050994-A1 |
priorityDate | 2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 275.